Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2025-12-24 @ 5:45 PM
NCT ID: NCT04823468
Eligibility Criteria: Inclusion Criteria: * Newly histologic diagnosis of nasopharyngeal carcinoma; * All genders, range from 18-70 years old; * Clinical stage II-IVa according to the 8th edition of the Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) staging system; * Patient-Generated Subjective Nutrition Assessment (PG-SGA) score ≤8; * Main organ functions test should be satisfied the following conditions: (1) Absolute neutrophil count (ANC) ≥1.5×10\^9/L; (2) Platelet (PLT) ≥80×10\^9/L; (3) Hemoglobin (Hb) ≥90 g/L; (4) Bilirubin \< 1.5 times the upper limit of normal value (ULN), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) \< 2.5 times the upper limit of normal value; (5) Creatinine \< 1.5 times the upper limit of normal value or creatinine clearance rate \>60 ml/min. Exclusion Criteria: * Patients whose energy intake is less than 60% of the target energy requirement for 3 days or more; * Have or are suffering from other malignant tumors; * Refuse concurrent chemoradiotherapy; * With diabetics, galactosemia, or sever metabolic diseases or endocrine diseases; * Cannot take oral or enteral nutrition, including intestinal obstruction, severe short bowel syndrome or high output fistula, or with severe digestive system diseases; * Known allergic reaction to any component of Abbott®Ensure, or severe allergic constitution; * Pregnant or lactating women; * With previous or ongoing clinical trials; * Refuse to sign inform consent form.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT04823468
Study Brief:
Protocol Section: NCT04823468